SUTRO BIOPHARMA INC
For the period ended Mar 29, 2024. Filed Apr 2, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Mar 29, 2024 · Filed Apr 2, 2024
STRO$9.62+4.6%Stored close · as of Nov 6, 2026
Contents
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 29, 2024
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.